Terumo Corporation
TRUMY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.39 | 1.87 | 22.65 | 2.13 |
| FCF Yield | 3.08% | 1.68% | 1.69% | 2.41% |
| EV / EBITDA | 16.74 | 18.51 | 14.35 | 16.24 |
| Quality | ||||
| ROIC | 7.41% | 6.55% | 6.44% | 6.90% |
| Gross Margin | 54.11% | 51.98% | 50.89% | 52.52% |
| Cash Conversion Ratio | 1.36 | 1.38 | 1.01 | 1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.10% | 9.44% | 10.14% | 3.80% |
| Free Cash Flow Growth | 90.12% | 48.92% | -32.66% | 75.60% |
| Safety | ||||
| Net Debt / EBITDA | -0.19 | 0.29 | 0.23 | 0.31 |
| Interest Coverage | 25.24 | 50.49 | 29.22 | 39.16 |
| Efficiency | ||||
| Inventory Turnover | 1.62 | 1.54 | 1.61 | 1.68 |
| Cash Conversion Cycle | 218.40 | 262.94 | 239.99 | 198.44 |